Teva Pharmaceutical Industries Ltd (TEVA)

11.69 +0.05  +0.43% NYSE Aug 13, 10:36 USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
11/06/2020 08:00 EST Misc Teva Pharmaceutical Industries Ltd Third Quarter Earnings Conference Call for 2020
11/06/2020 Earnings Teva Pharmaceutical Industries Ltd Third Quarter Earnings for 2020 Release
08/05/2020 08:00 EDT Misc Teva Pharmaceutical Industries Ltd Second Quarter Earnings Conference Call for 2020
08/05/2020 Earnings Teva Pharmaceutical Industries Ltd Second Quarter Earnings Result for 2020
06/09/2020 16:30 IST Misc Teva Pharmaceutical Industries Ltd Annual General Meeting for 2019
05/07/2020 08:00 EDT Misc Teva Pharmaceutical Industries Ltd First Quarter Earnings Conference Call for 2020
05/07/2020 07:00 EDT Earnings Teva Pharmaceutical Industries Ltd First Quarter Earnings Results for 2020
02/21/2020 Misc Teva Pharmaceutical Industries Ltd Annual Report for 2019
02/12/2020 08:00 EST Misc Teva Pharmaceutical Industries Ltd Fourth Quarter Earnings Conference Call for 2019
02/12/2020 07:00 EST Earnings Teva Pharmaceutical Industries Ltd Fourth Quarter Earnings Results for 2019
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.tevapharm.com
  • Investor Relations URL: http://ir.tevapharm.com/phoenix.zhtml?c=73925&p=irol-irhome
  • HQ State/Province: N/A
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Equity Style: Mid Cap/Value
  • Next Earnings Release: Nov. 06, 2020
  • Last Earnings Release: Aug. 05, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: Nov. 27, 2017
  • Description: Headquartered in Israel, Teva Pharmaceutical is the largest generic drug manufacturer in the world with roughly 60 manufacturing and R&D facilities. The company was formed in 1901 and has a portfolio of more than 3,500 medicines--roughly 1 out of 9 generic prescriptions in the U.S. is filled with a Teva product. The company also develops branded pharmaceuticals in the central nervous system, oncology, and respiratory categories. Teva's generic drug sales represent slightly over half of total revenue, with branded drug and distribution revenue making up the balance. Teva is an aggressive filer to bring generic drugs to market when brand patents expire and has the most generic products pending Food and Drug Administration approval.

Top Fund Holders

Symbol Name Weighting
EIS iShares MSCI Israel Capped ETF 9.80%
BMPEX Beck, Mack & Oliver Partners 4.70%
PPH VanEck Vectors Pharmaceutical ETF 4.41%
MVISX Miller Opportunity IS 4.20%
IZRL ARK Israel Innovative Technology ETF 2.75%
CCM8341 IA Clarington Global Opportunities FX 2.52%
MKIEX McKee International Equity Instl 2.24%
TAM003 Thornmark Dividend & Income 1.83%
MFCCX Meridian Contrarian C 1.73%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.